Form 4: Shattuck Labs Director Amy Kate Sasser Acquires Stock Options

Director Amy Kate Sasser acquired options to purchase 27,700 shares of Shattuck Labs common stock on June 21, 2024.

Summary

• Amy Kate Sasser, a director of Shattuck Labs, Inc. (STTK), filed a Form 4 on June 21, 2024.
• The filing reports the acquisition of stock options representing the right to purchase 27,700 shares of Shattuck Labs' common stock.
• These options were granted on June 21, 2024, with an exercise price of $4.37 per share.
• The options vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to continued service to the Issuer.
• Following the transaction, Sasser directly owns options for 27,700 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a director suggests confidence in the company, but it's a routine transaction.

Positives

• A director's acquisition of stock options can be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The vesting of the options is contingent on continued service to the Issuer, suggesting an incentive for the director to remain with the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation in the biotechnology industry.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in biotech companies like Shattuck Labs.
• Companies such as Amgen, Gilead Sciences, and Regeneron Pharmaceuticals also utilize stock options as part of their executive compensation plans to align management's interests with those of shareholders.

Stakeholder Impact

• The acquisition of stock options by a director can align their interests with those of shareholders, potentially leading to decisions that benefit the company's long-term value.

Key Dates